期刊文献+

多发性骨髓瘤患者CD_4^+IL-17A^+辅助性T细胞/CD_4^+CD_(25)^+Foxp3^+调节性T细胞及相关细胞因子的研究 被引量:8

Proportions of T Helper 17 Cells and Regulatory T Cells and Related Cytokines in Patients with Multiple Myeloma
下载PDF
导出
摘要 目的检测多发性骨髓瘤(MM)患者外周血CD4+IL-17A+辅助性T细胞(Th17细胞)/CD4+CD2+5Foxp3+调节性T细胞(Treg细胞)比率及相关细胞因子,分析其相关性。方法采用流式细胞术检测MM组初诊患者外周血Th17、Treg细胞占CD4+T细胞比例,ELISA法检测MM组初诊患者血清IL-17、IL-6、IL-23、TGF-β、IL-10水平。结果 MM患者外周血Th17细胞比率升高,Treg细胞比率降低,血清IL-6、IL-17与IL-23水平明显升高;MM患者外周血Th17细胞与Treg细胞含量呈负相关,Th17细胞含量与血清IL-6、IL-17、IL-23水平均呈正相关,Treg细胞含量与血清中IL-6、IL-17、IL-23水平均呈负相关。结论 MM患者存在Th17/Treg细胞失衡,IL-6、IL-17、IL-23影响两者表达,在MM发生发展中起重要作用。 Objective To observe the proportions of CD+4IL-17A+helper T cells(Th17 cells)and CD+4CD+25Foxp3+regulatory T cells(Tregs)and the related cytokines in the peripheral blood of multiple myeloma patients and to analyze their relationship.Methods The proportions of Treg and Th17cells in peripheral CD+4T cells were determined using flow cytometry.The expressions of peripheral serum IL-17,IL-6,IL-23,TGF-β,and IL-10 in untreated multiple myeloma patients with untreated were determined with enzyme-linked immunosorbent assay(ELISA).Results The proportion of Th17 cells increased,the proportion of Treg cells decreased,and the serum levels of IL-17,IL-6,and IL-23 increased in patients with untreated multiple myeloma.Th17 cells were negative correlated with Treg cells,whereas Th17 cells were positively correlated with IL-17,IL-6,and IL-23 and Treg cells were negatively correlated with these cytokines.Conclusion Imbalance between Treg and Th17 cells exist in multiple myeloma patients.IL-17,IL-6,and IL-23 can effect the expressions of Treg and Th17 cells and thus play roles in the development of multiple myeloma.
作者 杨青 金洁萍
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第20期2300-2303,共4页 Chinese General Practice
关键词 多发性骨髓瘤 TH17细胞 调节性T细胞 细胞因子 Multiple myeloma; T helper 17 cells; Regulatory T cells; Cytokines
  • 相关文献

参考文献17

  • 1Zhang ZN.Blood disease diagnosis and treatment standards[M].Version 3.Beijing:Science Press,2007:232-233. 被引量:1
  • 2Ritchie DS,Quach H,Fielding K,et al.Drug-mediated and cellular immunotherapy in multiple myeloma[J].Immunotherapy,2010,2(2):243-255. 被引量:1
  • 3Prabhala RH,Pelluru D,Fulciniti M,et al.Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma[J].Blood,2010,115(26):5385-5392. 被引量:1
  • 4Brimnes MK,Vangsted AJ,Knudsen LM,et al.Increased level of both CD+4FOXP3+ regulatory T cells and CD+14HLA-DR-/low myeloid-derived suppressor cells and decreased level of dendritic dells in patients with multiple myeloma[J].Scand Immunol J,2010,72(6):540-547. 被引量:1
  • 5Dhodapkar KM,Barbuto S,Matthews P,et al.Dendritic cells mediate the induction of polyfunctional human IL17-producing cells(Th17-1 cells)enriched in the bone marrow of patients with myeloma[J].Blood,2008:112(7):2878-2885. 被引量:1
  • 6Romagnani S.Human Th17 cells[J].Arthritis Res Ther,2008,10(2):206. 被引量:1
  • 7Miyahara Y,Odunsi K,Chen W,et al.Generation and regulation of human CD+4IL-17-produeing T cells in ovarian caneer[J].Proc Natl Aead Sci USA,2008,105(40):15505-15510. 被引量:1
  • 8Hideshima T,Mitsiades C,Tonon G,et al.Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets[J].Nat Rev Cancer,2007,7(8):585-598. 被引量:1
  • 9Ma J,Yu J,Tao X,et al.The imbalance between regulatory and IL-17-secreting CD+4T cells in lupus patients[J].Clin Rheumatol,2010,29(11):1251-1258. 被引量:1
  • 10Eastaff-Leung N,Mabarrack N,Barbour A,et al.Foxp3+regulatory T cells,Th17 effector cells,and cytokine environment in inflammatory bowel disease[J].J Clin Immunol,2010,30(1):80-89. 被引量:1

同被引文献87

  • 1Knutson KL, Disis ML. Salazar LG. CD4 regulatory T cells inhuman cancer pathogenesis. Cancer Immunol and Immunother,2007, 56(3):271-285. 被引量:1
  • 2Filaci G, Fenoglio D,Fravega,M. et al. CD8+ CD28- Tregulatory lymphocytes inhibiting T cell proliferativeandcytotoxic functions infiltrate human cancers. J Immunol, 2007,179(7): 4323-4334. 被引量:1
  • 3Thomson CW,Lee BP,Zhang L. Double-negative regulatory Tcells: non-conventional regulators. Immunol Res.2006,35(1-2):163-178. 被引量:1
  • 4Gershon RK, Kondo K. Cell interactions in the induction oftolerance: the role of thymic lymphocytes. Immunology, 1970,18(5):723-737. 被引量:1
  • 5Prabhala RH,Neri P, Bae JE, et al. Dysfunctional T regulatorycells in multiple myeloma. Blood, 2006,107( 1) : 301-304. 被引量:1
  • 6Lioznov M, El-Cheikh J Jr, Hoffmann F,et al. Lenalidomide assalvage therapy after allo-SCT for multiple myeloma is effectiveand leads to an increase of activated NK ( NKp44 ( + ) ) and T(HLA~DR( +)) cells. Bone Marrow Transplantation, 2010,45(2); 349-353. 被引量:1
  • 7Prabhala RH, Pelluru D, Fulciniti M,et al. Elevated IL-17produced by TH17 cells promotes myeloma cell growth andinhibits immune function in multiple myeloma. Blood,2010,115(26): 5385-5392. 被引量:1
  • 8Dhodapkar KM, Barbuto S, Matthews P, et al. Dendritic cellsmediate the induction of polyfunctional human IL17-producingcells ( Thl7-1 cells)enriched in the bone marrow of patients withmyeloma. Blood,2008,112(7) : 2878-2885. 被引量:1
  • 9Noonan K,Marchionni L, Anderson J,et al. A novel role of IL-17-producing lymphocytes in mediating lytic bone disease inmultiple myeloma. Blood, 2010,116(18) : 3554-3563. 被引量:1
  • 10Gupta R,Ganeshan P, Hakim M, et al. Significantly reducedregulatory T cell population in patients with untreated multiplemyeloma. Leuk Res, 2011,35(7) : 874-878. 被引量:1

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部